Ranitidin: Béda antarrépisi
Konten dihapus Konten ditambahkan
Tidak ada ringkasan suntingan |
Tidak ada ringkasan suntingan |
||
Baris ka-31:
|dependency_liability=
|addiction_liability=
|routes_of_administration= [[Oral administration|
|class = [[H2 antagonist|Histamine H<sub>2</sub> receptor antagonist]], aka H2 blocker<ref name=Patient.info/>
|ATCvet =
|ATC_prefix = A02
|ATC_suffix = BA02
|ATC_supplemental= <br>{{ATC|A02|BA07}} (
<!-- Legal status -->
|legal_AU= S2
Baris ka-58:
|bioavailability= 50% (Ngaliwatan baham)
|protein_bound = 15%
|metabolism = [[Liver]]: [[Flavin-containing monooxygenase|FMO]]s, including [[FMO3]];
|metabolites =
|onset = 55–65 minutes (150 mg dose)<ref name="pmid12144582"/><br>55–115 minutes (75 mg dose)<ref name="pmid12144582">{{cite journal|vauthors=Gardner JD, Ciociola AA, Robinson M, McIsaac RL|display-authors=3|title=Determination of the time of onset of action of ranitidine and famotidine on intra-gastric acidity|journal=Aliment. Pharmacol. Ther.|volume=16|issue=7|pages=1317–1326|date=July 2002|pmid=12144582|doi=10.1046/j.1365-2036.2002.01291.x|url= }}</ref>
|elimination_half-life= 2–3
|duration_of_action=
|excretion= 30–70% [[
<!-- Identifiers -->
|JAN =
|CAS_number_Ref = {{cascite|correct|??}}
|CAS_number = 66357-35-5
Baris ka-86:
|NIAID_ChemDB =
|PDB_ligand =
|synonyms = Dimethyl [(5-<nowiki/>{[(2-<nowiki/>{[1-(methylamino)-2-nitroethenyl]amino}ethyl)sulfanyl]methyl}furan-2-yl)methyl]
<!-- Chemical and physical data -->
|IUPAC_name = ''N''-(2-[(5-[(Dimethylamino)methyl]furan-2-yl)methylthio]ethyl)-''N'''-methyl-2-nitroethene-1,1-diamine
| |||